Characterization of a hepatitis B and hepatitis delta virus receptor binding site - PubMed (original) (raw)
Characterization of a hepatitis B and hepatitis delta virus receptor binding site
Matthias Engelke et al. Hepatology. 2006 Apr.
Abstract
Insights into the early infection events of the human hepatitis B (HBV) and hepatitis delta virus (HDV) have been limited because of the lack of a cell culture system supporting the full replication cycle for these important pathogens. The human hepatoma cell line HepaRG allows the experimental induction of a differentiated state, thereby gaining susceptibility toward HBV and HDV infection. We recently identified HBV envelope protein-derived lipopeptides comprising amino acids 2 though 48 of the preS-domain of the L-surface protein, which block infection already at picomolar concentrations. To map the responsible sequence for the peptides' activity we describe an Escherichia coli expression system that permits myristoylation and investigated recombinant HBVpreS-GST fusion proteins with deletion- and point-mutations for their ability to prevent HBV and HDV infection. We found that (1) a myristoylated HBVpreS/2-48-GST fusion protein efficiently interferes with HBV infection of HepaRG cells; (2) deletions and point mutations in the highly conserved preS1 sequence between amino acids 11 through 21 result in the loss of infection inhibition activity; (3) hepatitis B viruses carrying single amino acid exchanges within this region lose infectivity; and (4) HDV infection of HepaRG cells can be inhibited by myristoylated HBVpreS peptides with the same specificity. In conclusion, HBV and HDV use at least one common step to enter hepatocytes and require a highly conserved preS1-sequence within the L-protein. This step is exceptionally sensitive toward inactivation by acylated HBVpreS1 peptides, which therefore represent a novel group of entry inhibitors that could be used for the treatment of hepatitis B and D.
Similar articles
- Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein.
Gripon P, Cannie I, Urban S. Gripon P, et al. J Virol. 2005 Feb;79(3):1613-22. doi: 10.1128/JVI.79.3.1613-1622.2005. J Virol. 2005. PMID: 15650187 Free PMC article. - Role of the antigenic loop of the hepatitis B virus envelope proteins in infectivity of hepatitis delta virus.
Jaoudé GA, Sureau C. Jaoudé GA, et al. J Virol. 2005 Aug;79(16):10460-6. doi: 10.1128/JVI.79.16.10460-10466.2005. J Virol. 2005. PMID: 16051838 Free PMC article. - Analysis of the cytosolic domains of the hepatitis B virus envelope proteins for their function in viral particle assembly and infectivity.
Blanchet M, Sureau C. Blanchet M, et al. J Virol. 2006 Dec;80(24):11935-45. doi: 10.1128/JVI.00621-06. Epub 2006 Oct 4. J Virol. 2006. PMID: 17020942 Free PMC article. - Strategies to inhibit entry of HBV and HDV into hepatocytes.
Urban S, Bartenschlager R, Kubitz R, Zoulim F. Urban S, et al. Gastroenterology. 2014 Jul;147(1):48-64. doi: 10.1053/j.gastro.2014.04.030. Epub 2014 Apr 25. Gastroenterology. 2014. PMID: 24768844 Review. - Attachment sites and neutralising epitopes of hepatitis B virus.
Glebe D. Glebe D. Minerva Gastroenterol Dietol. 2006 Mar;52(1):3-21. Minerva Gastroenterol Dietol. 2006. PMID: 16554703 Review.
Cited by
- The HepaRG cell line: a valuable in vitro tool for hepatitis virus infection studies.
Ceelen L, Lieveld M, Forsyth R, Vinken M. Ceelen L, et al. Hepatol Int. 2013 Jun;7(2):394-9. doi: 10.1007/s12072-013-9428-1. Epub 2013 Feb 14. Hepatol Int. 2013. PMID: 26201773 - Hepatitis B Virus and Hepatitis D Virus Entry, Species Specificity, and Tissue Tropism.
Watashi K, Wakita T. Watashi K, et al. Cold Spring Harb Perspect Med. 2015 Aug 3;5(8):a021378. doi: 10.1101/cshperspect.a021378. Cold Spring Harb Perspect Med. 2015. PMID: 26238794 Free PMC article. Review. - Immunoadhesins containing pre-S domains of hepatitis B virus large envelope protein are secreted and inhibit virus infection.
Chai N, Gudima S, Chang J, Taylor J. Chai N, et al. J Virol. 2007 May;81(10):4912-8. doi: 10.1128/JVI.02865-06. Epub 2007 Feb 28. J Virol. 2007. PMID: 17329331 Free PMC article. - Identification of neutralizing epitopes in the preS2 domain of the hepatitis B virus.
Yato K, Matsuda M, Fukano K, Tanaka T, Moriishi K, Nishitsuji H, Shimotohno K, Tamura K, Wakita T, Muramatsu M, Kato T, Suzuki R. Yato K, et al. Virus Res. 2023 Jan 2;323:199014. doi: 10.1016/j.virusres.2022.199014. Epub 2022 Nov 26. Virus Res. 2023. PMID: 36511290 Free PMC article. - Viral and cellular determinants involved in hepadnaviral entry.
Glebe D, Urban S. Glebe D, et al. World J Gastroenterol. 2007 Jan 7;13(1):22-38. doi: 10.3748/wjg.v13.i1.22. World J Gastroenterol. 2007. PMID: 17206752 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials